Oncolytic Viruses

An oncolytic virus could be a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumors.Many number of viruses such as adenovirus, measles, simplex, Newcastle disease viruses have been clinically tested as oncolytic agents. Most current oncolytic viruses’ area unit designed for growth property, although there are naturally occurring examples such as reovirus and the senecavirus, resulting in clinical trials. The first oncolytic virus to be approved by a national social unit was genetically unqualified ECHO-7 strain animal virus RIGVIR, approved in Republic of Latvia in 2004 for the treatment of skin malignant melanoma.

 

    Related Conference of Oncolytic Viruses

    October 30-30, 2021

    2nd International Conference on Hepatitis

    London, UK
    November 23-24, 2021

    World Conference on Digestive and metabolic diseases

    Hanoi, Vietnam
    December 02-03, 2021

    4th World Liver Congress

    Amsterdam, Netherlands
    February 21-22, 2022

    17th Euro-Global Gastroenterology Conference

    Berlin, Germany
    June 13-14, 2022

    28th World Conference on Gastroenterology & Hepatology

    Amsterdam, Netherlands
    July 18-19, 2022

    International Conference on Gastroenterology and Liver

    Amsterdam, Netherlands
    July 20-21, 2022

    21th World Gastroenterologists Summit

    Osaka, Japan

    Oncolytic Viruses Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in